To fully recognize the value of big data within our organizations, we must have a laser sharp focus on getting data out. In today’s data-driven world where many large organizations have made the investment in the platform and have the data aggregated, the big question is “what do we with the data to really drive competitive advantage?” At this session, discover how one big Pharma is changing the game, and learn about the pitfalls and the opportunities you need to be mindful of in helping your organization capitalize on one of its biggest assets.
Kimberly Tableman, Clinical Data Domain Owner
Kimberly is a Clinical Data Domain Owner at GlaxoSmithKline with an eye towards leveraging data for competitive advantage. She has also worked at Cap Gemini Ernst & Young, at ESPN and at Pfizer – where she took on roles of increasing leadership in Clinical Development Quality, Global Clinical Trial Execution, Business Operations and Development Analytics. She is passionate about providing leadership and partnering to move organizations forward. Kimberly is an RLF grad and earned a BSBA in Management Information Systems from Central Michigan University and a Masters of Science in Information and Knowledge Strategies from Columbia University.